Pharma Research Data Protection Agent
XenonStack · Cybersecurity & IT
Certification per Microsoft Marketplace.
Evidence tier Source Confirmed · 8 captures on record
What the publisher says
As described on Microsoft Marketplace.
Overview
ElixirClaw (Agentic OS) enables autonomous yet governed protection of pharmaceutical research data and intellectual property. It detects data exfiltration attempts, enforces data loss prevention (DLP) policies, and orchestrates investigation workflows while ensuring strict human-in-the-loop controls for regulatory and access-sensitive actions.
Show the rest of the publisher’s description (25 more lines)
Key Benefits
- Real-time detection of data exfiltration and unauthorized access
- Automated enforcement of DLP policies across research systems
- Protection of clinical trial data and intellectual property
- Governed execution with human approval for high-impact actions
- Faster response to data security incidents
- Full traceability of actions for audit and complianceHow It Works
ElixirClaw integrates with research systems, document repositories, collaboration tools, identity platforms, and data monitoring solutions.
When suspicious activity is detected—such as abnormal downloads, unauthorized data access, or potential exfiltration—the agent evaluates policies and initiates response workflows. These include enforcing DLP rules, restricting access, and triggering investigation or escalation processes.
All actions are governed through policy gates. Sensitive actions such as access revocation or regulatory reporting require explicit human approval to ensure compliance and operational control.
Each action generates a Decision Trace capturing context, policy validation, approvals, and execution outcomes, ensuring full transparency and auditability.
Business Impact
- Reduced risk of research data leakage and IP theft
- Faster response to data security incidents
- Improved compliance with regulatory requirements
- Enhanced protection of clinical trial and proprietary data
- Reduced manual workload for security teams
- Increased trust in data governance and security processesIdeal For
- Pharmaceutical companies managing clinical and research data
- CISOs responsible for IP protection and compliance
- VP Research IT Security overseeing data access and governance
- Organizations handling sensitive trial data and intellectual propertyIndustries
- Pharmaceuticals
- Healthcare & Life Sciences
- Biotechnology
Preview
3 images
Agent build and provenance
See the full provenance
The layer-by-layer build, the evidence behind each claim, the risk basis and the cross-marketplace links are open to any account. Some rows are disclosed, some the source leaves Unknown; a free account shows you which.
Compliance
- FedRAMPConfirmedNot listed90%, registry-checkedNo FedRAMP Marketplace entry matched this vendor's domain, checked 2026-08-27registry recordas observed 2026-08-27
Confirmed means matched to a public authoritative registry. Claimed means the vendor or its listing states it, not yet cross-checked. A framework not shown was not found in any source we hold, which is not evidence against it. Not listed means a scoped registry check found no match for this vendor's domain: a No is a scoped registry check, not a compliance judgment. Confidence bands: 95% domain-verified, 90% registry-checked, 80% self-attested, 70% weak signal. Self-attested items marked “vendor's site” are gathered from the vendor's own website and are not verified by us.
Vendor
External enrichment · as of 2026-08-29
Sources
Publisher resources
4 linksLinked repositories
Unknown means this listing does not publish a repository. It is not a statement that the code is closed, and a linked repository is not a claim that the publisher wrote it: the registry computes that relationship privately and does not publish it.
Evidence risk is the share of the build you cannot see before you deploy, not a security rating. Sign in to see the layer-by-layer basis for this band.